Asprosin protects against ischemia/reperfusion-induced kidney injury in mice
- Tuba Keskin 1, Engin Korkmaz 1, Azibe Yıldız 2, Çiğdem Tekin 3, Ali Beytur 4, Suat Tekin 5
- Tuba Keskin 1, Engin Korkmaz 1, Azibe Yıldız 2
- 1Department of Physiology, Faculty of Medicine, Inonu University, Malatya, Turkey.
- 2Department of Histology and Embryology, Faculty of Medicine, Inonu University, Malatya, Turkey.
- 3Vocational School of Health Services, Inonu University, Malatya, Turkey.
- 4Department of Urology, Faculty of Medicine, Inonu University, Malatya, Turkey.
- 5Department of Physiology, Faculty of Medicine, Inonu University, Malatya, Turkey. suat.tekin@inonu.edu.tr.
- 0Department of Physiology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Asprosin (ASP) protects against kidney injury caused by ischemia-reperfusion (IR). This hormone reduced inflammation, oxidative stress, and apoptosis, improving kidney function in a mouse model.
Area Of Science
- Nephrology
- Endocrinology
- Pathophysiology
Background
- Ischemia-reperfusion (IR) injury is a major cause of acute kidney injury (AKI).
- Inflammation, oxidative stress, and apoptosis are key mechanisms in IR-induced AKI.
- Asprosin (ASP), a fasting hormone, impacts oxidative and apoptotic pathways.
Purpose Of The Study
- To investigate the renoprotective potential of ASP in a murine model of IR-induced AKI.
- To evaluate ASP's effects on renal function, inflammation, oxidative stress, and apoptosis.
Main Methods
- Male Balb/c mice were subjected to 22 minutes of renal ischemia followed by 24 hours of reperfusion.
- Mice received intravenous ASP (1 or 10 µg/kg) or vehicle pretreatment.
- Renal function, inflammatory cytokines (IL-1β, TNF-α), oxidative stress markers (MDA, SOD, CAT), and caspase-3 expression were assessed.
- Kidney histopathology was evaluated using hematoxylin-eosin staining.
Main Results
- IR significantly elevated kidney injury markers (BUN, creatinine), inflammation (IL-1β, TNF-α), oxidative stress (MDA), and apoptosis (caspase-3).
- IR reduced antioxidant enzyme activity (SOD, CAT).
- ASP pretreatment dose-dependently reversed these detrimental effects, improving renal function and reducing tissue damage.
Conclusions
- Asprosin demonstrates significant renoprotective effects against IR-induced AKI in mice.
- ASP alleviates kidney injury by mitigating inflammation, oxidative stress, and apoptosis.
- ASP holds promise as a therapeutic agent for preventing or treating IR-induced AKI.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

